{
  "meta": {
    "title": "Mini_Test_11-_Drugs_Of_Choice_Only",
    "url": "https://brainandscalpel.vercel.app/mini-test-11-drugs-of-choice-only-d1dae8e4.html",
    "scrapedAt": "2025-11-30T12:45:55.834Z"
  },
  "questions": [
    {
      "text": "A 36-year-old male HIV patient presents to the ED with a cough with bloody sputum. He also has night sweats, chills, and difficulty in breathing. A chest X-ray and examination of the sputum show the following findings. Which of the following is the drug of choice for his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Amikacin"
        },
        {
          "id": 2,
          "text": "Cotrimoxazole"
        },
        {
          "id": 3,
          "text": "Minocycline"
        },
        {
          "id": 4,
          "text": "Linezolid"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario along with the chest X-ray and gram-staining is suggestive of&nbsp;<strong>Nocardiosis.</strong>&nbsp;The drug of choice is&nbsp;<strong>cotrimoxazole.</strong></p>\n<p><em>Nocardia</em> is a <strong>gram-positive</strong> and acid-fast bacteria.&nbsp;Nocardia pneumonia has a sub-acute presentation with mostly cough with thick sputum and fever. Generally, hemoptysis is uncommon. Chest radiography shows <strong>nodular infiltrations</strong> involving bilateral lung fields.</p>\n<p>Extrapulmonary manifestations are common, the <strong>brain</strong> is the most commonly involved organ. It is associated with dense bilateral infiltrates with cavitating nodules and subacute brain abscesses.</p>\n<p>The drug of choice is&nbsp;<strong>cotrimoxazole.&nbsp;</strong>Severe disease is treated with a combination of cotrimoxazole, amikacin, and ceftriaxone, or imipenem.</p><p>Note: Mnemonic&nbsp;<strong>SNAP:&nbsp;</strong></p>\n<p><strong>S</strong>ulfamethoxazole-trimethoprim (Cotrimoxazole) is the drug of choice for&nbsp;<strong>N</strong>ocardia.</p>\n<p>For<strong> A</strong>ctinomyces,&nbsp;<strong>P</strong>enicillins are the drugs of choice.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dfacc98188c14e3e8fb1003ce4308a40.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3600",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old female patient came with complaints of amenorrhea for 6 weeks. The urine pregnancy test was positive. Her thyroid profile is given below. She reports that her mother has Graves disease. What is the drug of choice for her present condition?<div class='question-desc-html'><p>Thyroid-stimulating hormone (TSH) - decreased</p>\n<p>T<span>4</span>&nbsp;- increased</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Propylthiouracil"
        },
        {
          "id": 2,
          "text": "Methimazole"
        },
        {
          "id": 3,
          "text": "Carbimazole"
        },
        {
          "id": 4,
          "text": "Levothyroxine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above clinical features are suggestive of <strong>hyperthyroidism</strong>&nbsp;in the&nbsp;<strong>1<sup>st</sup> trimester of pregnancy.&nbsp;Propylthiouracil</strong> is the drug of choice for this patient.&nbsp;</p>\n<p>Propylthiouracil is an antithyroid drug that belongs to the group of <strong>thioamides</strong>. It inhibits the&nbsp;<strong>peroxidase enzyme, </strong>which&nbsp;catalyzes&nbsp;<strong>the coupling reaction of iodotyrosyl residues; </strong>thus reducing thyroid hormone synthesis. Propylthiouracil also inhibits <strong>peripheral iodothyronine deiodination</strong>.</p>\n<p>Uses:</p>\n<ul>\n<li>As a definitive treatment and to control remission in <strong>Graves disease</strong></li>\n<li>In conjunction with radioactive iodine</li>\n<li><strong>Preoperatively</strong> to control the disorder requiring surgery</li>\n</ul>\n<p>Adverse effects:</p>\n<ul>\n<li><strong>Agranulocytosis</strong> is reversible once the drug is stopped</li>\n<li><strong>Most common</strong> is <strong>urticarial rash</strong></li>\n<li><strong>Teratogenic</strong> potential limited to methimazole and carbimazole leading to\n<ul>\n<li><strong>Fetal aplasia cutis&nbsp;</strong></li>\n<li><strong>Choanal </strong>and<strong> esophageal atresia</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Propylthiouracil</strong> does <strong>not</strong> cross the <strong>placental barrier</strong> whereas <strong>methimazole </strong>and<strong> carbimazole</strong> <strong>cross</strong> the placental barrier leading to teratogenicity. Therefore, propylthiouracil is the drug of choice for hyperthyroidism in&nbsp;1<sup>st</sup> trimester of pregnancy (period of organogenesis). Propylthiouracil use is limited to the first trimester due to the risk of hepatotoxicity, following which it is replaced with methimazole (or carbimazole) in the 2<sup>nd</sup> and 3<sup>rd</sup> trimesters.</p>\n<p>Other options:</p>\n<p>Option D: <strong>Levothyroxine</strong> is a thyroid hormone preparation used in the treatment of <strong>hypothyroidism</strong> and <strong>myxedema coma.</strong></p><hr><h3>Related Pearl: Drug of choice for hyperthyroidism/thyrotoxicosis in pregnancy</h3><p>In the 1st trimester: <strong>Propylthiouracil</strong></p>\n<p>In the 2nd and 3rd trimester: <strong>Methimazole</strong></p><hr><h3>Related Pearl: Teratogenic drugs and the birth defects</h3><table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Adverse effects</strong></td>\n</tr>\n<tr>\n<td>Penicillamine</td>\n<td>Cutis laxa syndrome</td>\n</tr>\n<tr>\n<td><strong>Lithium</strong></td>\n<td><strong>Ebstein anomaly</strong></td>\n</tr>\n<tr>\n<td>Isotretinoin</td>\n<td>Facial-ear anomalies, heart disease, CNS anomalies</td>\n</tr>\n<tr>\n<td>Progesterone</td>\n<td>Masculinization of the female fetus</td>\n</tr>\n<tr>\n<td>Quinine</td>\n<td>Abortion, thrombocytopenia, deafness</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Cleft lip</td>\n</tr>\n<tr>\n<td><strong>Valproate</strong></td>\n<td>Spina bifida, limb defects, <strong>autism spectrum disorder</strong>, facial and cardiac anomalies, <strong>Coarctation of the aorta</strong>, Aortic stenosis, Pulmonary atresia, Ventricular Septal Defect. </td>\n</tr>\n<tr>\n<td><strong>Vitamin D</strong></td>\n<td><strong>Supravalvular aortic stenosis</strong></td>\n</tr>\n<tr>\n<td><strong>Warfarin</strong></td>\n<td>Fetal bleeding, <strong>hypoplastic nasal structures</strong></td>\n</tr>\n<tr>\n<td><strong>Statins</strong></td>\n<td>Vertebral, anal, cardiac, tracheoesophageal fistula, renal, arterial, limb (<strong>VACTERAL</strong>) defects</td>\n</tr>\n<tr>\n<td><strong>Phenytoin</strong></td>\n<td>Ventricular septal defect, Atrial Septal Defect, Coarctation of the aorta, Patent Ductus Arteriosus</td>\n</tr>\n<tr>\n<td>ACE inhibitors and ARBs</td>\n<td>\n<p>Hypoplasia of organs, anuria, irreversible renal failure</p>\n</td>\n</tr>\n<tr>\n<td>Carbimazole and Methimazole</td>\n<td> \n<p>Choanal atresia, aplasia cutis, tracheoesophageal fistula and fetal goiter</p>\n</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Atrial Septal Defect, Ventricular Septal Defect</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1930",
      "difficulty": "easy"
    },
    {
      "text": "A 42-year-old man involved in a road traffic accident was brought to the emergency room. His vitals are as shown below. His vitals did not improve on fluid resuscitation. On FAST examination, there was fluid present in the retroperitoneal space. The patient was shifted to the operating room for laparotomy. What is the intravenous agent of choice for this patient?<div class='question-desc-html'><ul>\n<li>Pulse rate- 100 bpm</li>\n<li>Blood pressure(BP)- 80/40 mmHg</li>\n<li>SpO<sub>2</sub>- 95%</li>\n<li>Respiratory rate- 30 per minute</li>\n<li>GCS- 15/15</li>\n</ul>\n<p>(FAST- Focussed Assessment of Sonography in Trauma)</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Ketamine"
        },
        {
          "id": 2,
          "text": "Propofol"
        },
        {
          "id": 3,
          "text": "Thiopentone"
        },
        {
          "id": 4,
          "text": "Midazolam"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Ketamine&nbsp;</strong>is the intravenous agent of choice in this patient. Ketamine indirectly <strong>stimulates</strong> the <strong>cardiovascular system</strong>&nbsp;and is thus useful in this patient as he has come with a traumatic injury to the abdomen and is <strong>hemodynamically unstable</strong>.</p>\n<p>Ketamine is a <strong>phencyclidine</strong> derivative that inhibits <strong>NMDA&nbsp;</strong>(N-methyl-D-aspartate) <strong>receptors</strong> resulting in a decrease in excitatory stimulation by glutamate in the brain.&nbsp;It is a strong <strong>analgesic</strong> and <strong>amnestic </strong>agent.&nbsp;It also causes <strong>dissociative anesthesia</strong>.</p>\n<p>On the cardiovascular system, it directly has a cardio-depressive effect and <strong>indirectly</strong> stimulates it by activating the <strong>sympathetic system&nbsp;</strong>and inhibiting the vagus nerve.&nbsp;It <strong>predominantly</strong> shows a <strong>stimulatory</strong> effect hence causing tachycardia, increased cardiac output, and <strong>increased</strong> systemic and pulmonary <strong>hypertension</strong>.</p>\n<p>On the respiratory system, it has a <strong>bronchodilator</strong> effect on bronchial smooth muscles. It increases salivary secretion and bronchial secretion.&nbsp;It also acts on other systems and increases the intracranial and intraocular pressures.</p>\n<p>Uses:</p>\n<ul>\n<li>Ketamine is the <strong>intravenous agent of choice</strong> for patients with <strong>shock</strong>, <strong>low cardiac output states,</strong> and <strong>reactive airway diseases.</strong></li>\n<li>It is also used in patients with congenital heart diseases, especially with&nbsp;<strong>right-to-left shunts</strong></li>\n<li><strong>Perioperative analgesia</strong></li>\n</ul>\n<p>Ketamine should be <strong>avoided</strong> in patients with a history of seizures, psychiatric illness, or vascular aneurysms. It is also contraindicated in open eye injuries and eye surgeries</p>\n<p>Adverse effects:</p>\n<ul>\n<li><strong>Hallucination</strong> is the most common side effect of ketamine.</li>\n<li><strong>Emergence reaction</strong> (vivid dreaming, illusion, etc)</li>\n<li>Increases brain oxygen consumption and metabolic rate leading to increased intracranial tension.</li>\n</ul>\n<p>Other options:</p>\n<p>Option B:&nbsp;<strong>Propofol</strong> is the most commonly used parenteral anesthetic. It is cerebro-protective by decreasing cerebral metabolic rate. It produces dose-dependent hypotension.</p>\n<p>Option C:<strong> Thiopentone</strong> belongs to the barbiturate group. It is cerebro-protective and is an anticonvulsant. It leads to <strong>hypotension</strong> due to vasodilation. It is <strong>contraindicated</strong> in&nbsp;patients with obstructive airway disease, severe <strong>cardiovascular instability,</strong> and shock, history of porphyrias.</p>\n<p>Option D:&nbsp;<strong>Midazolam</strong> is a benzodiazepine. It is used in treating seizures and is used in daycare surgeries as an induction agent due to its short half-life.</p><hr><h3>Related Pearl: A list of anaesthetics and their physiological effects</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition</strong></p>\n</td>\n<td>\n<p><strong>Anesthetics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Increased Intracranial tension (ICT)</strong></p>\n</td>\n<td>\n<p>Sevoflurane</p>\n<p>Desflurane</p>\n<p>Isoflurane</p>\n<p>Enflurane</p>\n<p>Methoxiflurane</p>\n<p>Halothane</p>\n<p>Ketamine</p>\n<p>Nitrous Oxide (N2O)</p>\n<p>Succinyl-choline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Decreased ICT</strong></p>\n</td>\n<td>\n<p>Barbiturates (e.g.thiopentone)</p>\n<p>Benzodiazepines</p>\n<p>Cyclopropane</p>\n<p>Droperidol</p>\n<p>Etomidate</p>\n<p>Lidocaine</p>\n<p>Propofol</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Increased Intraocular pressure (IOP)</strong></p>\n</td>\n<td>\n<p>Barbiturates (e.g. thiopentone)</p>\n<p>Cyclopropane</p>\n<p>Etomidate</p>\n<p>Succinyl Choline</p>\n<p>Ketamine</p>\n<p>N2O</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Decreased IOP</strong></p>\n</td>\n<td>\n<p>Morphine</p>\n<p>Halothane</p>\n<p>Hexamethonium</p>\n<p>Trimethaphan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Increased Blood pressure</strong></p>\n</td>\n<td>\n<p>Ketamine</p>\n<p>Pentazocin</p>\n<p>Pancuronium</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bronchodilation (preferred in asthamatics)</strong></p>\n</td>\n<td>\n<p>Ketamine (most potent)&nbsp;</p>\n<p>Sevofluorane</p>\n<p>Halothane&nbsp;</p>\n<p>Promethazine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bronchospasmodics (contraindicated in asthamatics)</strong></p>\n</td>\n<td>\n<p>d-TC</p>\n<p>N2O</p>\n<p>Thiopentone</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1936",
      "difficulty": "medium"
    },
    {
      "text": "A 56-year-old male patient with a history of diabetes mellitus was diagnosed with major depression. He attempted suicide by consuming a bottle of glipizide tablets. What is the antidote of choice for this case?",
      "choices": [
        {
          "id": 1,
          "text": "Glucagon"
        },
        {
          "id": 2,
          "text": "Octreotide"
        },
        {
          "id": 3,
          "text": "Intravenous dextrose"
        },
        {
          "id": 4,
          "text": "Leucovorin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The antidote of choice for the above case scenario suggestive of <strong>sulfonylurea overdose </strong>(glipizide belongs to the sulfonylurea group) which resulted in <strong>severe hypoglycemia</strong> is <strong>o</strong><strong>ctreotide</strong>.</p>\n<p>Octreotide is a <strong>somatostatin analogue</strong>. It inhibits the secretion of growth hormone. It binds to <strong>somatostatin-2</strong> receptors on <strong>pancreatic beta cells</strong> and <strong>blocks</strong> the <strong>Ca<sup>2+</sup> influx</strong> resulting in a <strong>decrease </strong>in<strong> insulin secretion</strong>. Hence, it can be used to correct the hypoglycemia caused by sulfonylurea. overdose.</p>\n<p>Other uses of octreotide:</p>\n<ul>\n<li><strong>Acromegaly</strong></li>\n<li><strong>Esophageal varices</strong></li>\n<li>Thyrotrope adenomas</li>\n<li><strong>Carcinoid tumors</strong></li>\n<li>Adenomas secreting VIP(watery diarrhea)</li>\n<li>Diagnostic imaging of neuroendocrine tumors</li>\n<li><strong>Sulfonylurea toxicity</strong></li>\n</ul>\n<p>Adverse effects: </p>\n<ul>\n<li>Injection site pain</li>\n<li>Hyperglycemia</li>\n<li><strong>Gallstones</strong></li>\n</ul>\n<p>Other options: </p>\n<p>Option A: <strong>Glucagon</strong> can rectify hypoglycemia by promoting glycogenolysis and gluconeogenesis. However, it is not routinely administered as it can stimulate insulin release and is not useful in glycogen-depleted patients.</p>\n<p>Option C: <strong>Intravenous dextrose</strong> is not given because when administered it creates a hyperglycemic state thus stimulating insulin release, causing hypoglycemia again.</p>\n<p>Option D: <strong>Leucovorin </strong>(folinic acid) is the antidote of choice for <strong>methotrexate overdose</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1957",
      "difficulty": "hard"
    },
    {
      "text": "A patient with calcium oxalate monohydrate crystals in the urine is diagnosed with ethylene glycol poisoning. What is the drug of choice for treating this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium bicarbonate"
        },
        {
          "id": 2,
          "text": "Fomepizole"
        },
        {
          "id": 3,
          "text": "Thiamine"
        },
        {
          "id": 4,
          "text": "Ethanol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Fomepizole</strong> is the drug of choice for the treatment of<strong> ethylene glycol poisoning.</strong></p>\n<p>Treatment of ethylene glycol poisoning:</p>\n<ul>\n<li><strong>Fomepizole</strong> (preferred) or <strong>ethanol</strong> (if fomepizole is unavailable) - inhibits the enzyme alcohol dehydrogenase</li>\n<li><strong>Sodium bicarbonate</strong>&nbsp;- correct systemic acidosis</li>\n<li><strong>Hemodialysis</strong>&nbsp;- for elevated toxic alcohol levels, severe acid-base derangements, or evidence of end-organ toxicity</li>\n<li><strong>Co-factors</strong> (folic acid, thiamine, and pyridoxine) - optimizes non-toxic metabolic pathways for the elimination of parent alcohol or its metabolites</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3850",
      "difficulty": "medium"
    },
    {
      "text": "A 54-year-old female patient came with complaints of easy fatiguability and back pain for the past 2 months. She gives a history of night sweats, dry skin, vaginal dryness, decrease libido since one year, and a right wrist fracture 3 months back. On investigation, her T-score is found to be –2.6. What is the drug of choice for her present complaint?",
      "choices": [
        {
          "id": 1,
          "text": "Estrogen"
        },
        {
          "id": 2,
          "text": "Zolendronate"
        },
        {
          "id": 3,
          "text": "Teriparatide"
        },
        {
          "id": 4,
          "text": "Denosumab"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Zoledronate&nbsp;</strong>(bisphosphonates) is the drug of choice for her present complaint i.e., back pain. The given clinical scenario is suggestive of <strong>post-menopausal osteoporosis</strong> and bisphosphonates are the drug of choice for this condition.</p>\n<p>Zoledronate mainly targets the calcium of <strong>remodeling bone</strong>. It inhibits bone resorption by inducing <strong>apoptosis</strong> of <strong>osteoclast</strong> and <strong>inhibition</strong> of the&nbsp;<strong>cholesterol biosynthesis pathway.</strong>&nbsp;</p>\n<p>Therapeutic uses:</p>\n<ul>\n<li><strong>Post-menopausal </strong>and<strong> steroid-induced osteoporosis</strong></li>\n<li><strong>Paget's disease</strong></li>\n<li>Tumor-induced osteolysis</li>\n<li>Hypercalcemia</li>\n</ul>\n<p>Adverse effects:</p>\n<ul>\n<li>Oral intake causes <strong>esophagitis</strong> and <strong>esophageal erosion</strong>.</li>\n<li>Intravenous intake causes <strong>infusion reactions</strong> like skin flushing, flu-like symptoms, muscle, and joint aches.</li>\n<li><strong>Nephrotoxicity</strong></li>\n<li>Hypocalcemia</li>\n<li><strong>Osteonecrosis of jaw bone</strong></li>\n<li>Increased risk of femoral shaft fractures</li>\n</ul>\n<p>Postmenopausal osteoporosis is an exaggerated form of bone depletion that accompanies aging and loss of gonadal activity. Other risk factors of osteoporosis are:</p>\n<ul>\n<li><strong>Age</strong></li>\n<li><strong>Female sex</strong></li>\n<li class=\"p1\">Alcohol</li>\n<li class=\"p1\">Smoking</li>\n<li class=\"p1\">Previous history of fragility fractures</li>\n<li class=\"p1\">Family history of hip fracture</li>\n<li class=\"p1\">Low body mass index- less than 18.5 kg/m<sup><span class=\"s1\">2</span></sup></li>\n<li class=\"p1\">Excessive usage of <strong>glucocorticoids</strong></li>\n</ul>\n<p>They present with fractures that occur without any trauma or as a result of low-impact trauma. The commonly associated fractures are fractures of the distal part of the <strong>radius</strong> (Colle's fracture), fractures of the<strong>&nbsp;hip</strong>, and fractures of the&nbsp;<strong>vertebrae</strong>.&nbsp;</p>\n<p>Other options:&nbsp;</p>\n<p>Option A: <strong>Estrogen</strong> supplementation is <strong>not</strong> effective for postmenopausal osteoporosis.</p>\n<p>Option C: <strong>Teriperatide</strong> is a <strong>parathormone analogue</strong> that is used in the treatment of severe osteoporosis (T-score &lt; &ndash;2.5).</p>\n<p>Option D: <strong>Denosumab</strong> is a <strong>monoclonal antibody</strong> against <strong>RANK receptors</strong> and is used for severe osteoporosis (T-score &lt; &ndash;2.5).</p><hr><h3>Related Pearl: Z-score and T-score for osteoporosis:</h3><p><strong><span>Z-score:</span></strong></p>\n<p><span>It is the number of standard deviations a patient’s BMD(bone mass density) differs from the average BMD of <strong>their age, sex, and ethnicity</strong>.</span></p>\n<p><span>A Z-score of -2 or below should trigger investigations for underlying disease.</span></p>\n<p><strong><span>T-score:</span></strong></p>\n<p><span>It is the BMD at the site when compared to the <strong>young normal reference</strong> mean. It is a comparison of a patient’s BMD to that of a healthy <strong>30-year old</strong>.</span></p>\n<ul>\n<li><span><strong>Normal</strong> is a T-score of -1 or higher.</span></li>\n<li><span><strong>Osteopenia</strong> is defined as a T-score between -1.0 and -2.5.</span></li>\n<li><span><strong>Osteoporosis</strong> is defined as a T-score less than -2.5, that is a BMD which is two and a half standard deviations below the mean of a 30-year old man/woman.</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1916",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old man who just came back from a trip to Brazil presents with fever, headache, and rash for the last 3 days. He is diagnosed with Rocky Mountain spotted fever. Which of the following correctly describes the mechanism of action of the drug which should be used to treat him?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibits DNA gyrase, topoisomerase IV"
        },
        {
          "id": 2,
          "text": "Acts on 50s subunit and inhibits protein synthesis"
        },
        {
          "id": 3,
          "text": "Acts on transpeptidase and inhibits cell wall synthesis"
        },
        {
          "id": 4,
          "text": "Acts on 30s subunit and inhibits protein synthesis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Doxycycline</strong> is the drug of choice for <strong>Rocky Mountain spotted fever</strong>. It belongs to the <strong>tetracycline</strong> group of antimicrobials. It acts on the&nbsp;<strong>30s bacterial ribosome subunit</strong> and inhibits bacterial protein synthesis.</p>\n<p>Therapeutic uses of tetracyclines include:</p>\n<ul>\n<li><strong>Rickettsial infections</strong> such as <strong>Rocky Mountain spotted fever</strong>, scrub typhus, and Q fever</li>\n<li><strong>Pneumonia</strong> due to <em>Steptococcus pneumonia</em>, <em>H. influenzae&nbsp;</em>and atypical organisms</li>\n<li><strong>Sexually transmitted infections</strong> like <em>Chlamydia</em> <em>trachomatis</em></li>\n<li>Prevention and treatment of <strong>anthrax</strong></li>\n<li><em>Brucella</em>, <em>Bartonella</em>, <em>Borrelia</em> infections</li>\n<li><em>Mycobacterium marinum&nbsp;</em>(swimming pool granuloma)</li>\n</ul>\n<p>Tetracyclines are incompletely absorbed from the gut, leading to <strong>alteration of the gut flora</strong> due to the high concentration which is left unabsorbed in the intestines. This can cause an <strong>overgrowth of some organisms</strong> such as <strong>yeasts</strong>, <em><strong>Enterococci</strong></em> and <em><strong>Pseudomonas</strong></em> during prolonged tetracycline therapy. <strong>Children</strong> treated with tetracyclines may develop <strong>permanent brown discoloration of the teeth</strong>. The <strong>teratogenic</strong> effect associated with tetracyclines is their <strong>deposition in the fetal skeleton</strong> during pregnancy and <strong>depression of bone growth</strong> in infants.</p>\n<p><strong>Hepatotoxicity</strong> and <strong>nephrotoxicity</strong> can also occur. <strong>Demeclocycline</strong> causes <strong>nephrogenic diabetes insipidus</strong>, and has been used for the <strong>treatment of SiADH</strong>. Other side effects include <strong>idiopathic intracranial hypertension</strong> and vestibular toxicity.</p>\n<p>The main mechanism of <strong>resistance</strong> to tetracyclines is by a <strong>decreased antibiotic influx</strong> or acquisition of an <strong>energy-dependent efflux pump</strong> for the drug. Other mechanisms include a ribosomal protein that displaces tetracycline from its target and enzymatic inactivation of tetracyclines.</p>\n<p>Other options:</p>\n<p>Option A: Inhibition of <strong>DNA gyrase, topoisomerase IV</strong> is the mechanism of action of <strong>fluoroquinolones</strong>.</p>\n<p>Option B: The antibiotics which act on the <strong>50s subunit of bacterial ribosome</strong> include&nbsp;<strong>chloramphenicol</strong>, <strong>macrolides</strong>, <strong>clindamycin</strong>, <strong>linezolid,</strong> and <strong>streptogramins</strong>.</p>\n<p>Option C: Blocking of the <strong>transpeptidase enzyme</strong> and <strong>inhibition of cell wall synthesis</strong> is the mechanism of action of <strong>penicillins</strong>.</p><hr><h3>Related Pearl: Protein synthesis inhibitors: Primary subunit of ribosome binding</h3><p>Mnemonic: 50 <strong>CELLS</strong> arranged into 30 <strong>TEAM</strong></p>\n<p>50s subunit binding:</p>\n<ul>\n<li><strong>C</strong>: Chloramphenicol, Clindamycin</li>\n<li><strong>E</strong>: Erythromycin (macrolides)</li>\n<li><strong>L</strong>: Lincosamides</li>\n<li><strong>L</strong>: Linezolid</li>\n<li><strong>S</strong>: Streptogramins</li>\n</ul>\n<p>30s subunit binding</p>\n<ul>\n<li><strong>Te</strong>: Tetracyclines</li>\n<li><strong>Am</strong>: Aminoglycosides</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1922",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old male patient diagnosed with Parkinson's disease is on levodopa for 1 year. He developed involuntary, rapid, irregular movements of hands, face, and legs 2 days back. What is the first line of treatment for the above presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Apomorphine"
        },
        {
          "id": 2,
          "text": "Entacapone"
        },
        {
          "id": 3,
          "text": "Amantadine"
        },
        {
          "id": 4,
          "text": "Selegiline"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical scenario is suggestive of <strong>levodopa-induced dyskinesia. </strong>The first line of treatment for this condition is <strong>Amantadine</strong>.</p>\n<p>Normally, dopamine in the nigrostriatal pathway provides continuous (tonic) stimulation to the dopaminergic receptors in the striatum. In Parkinson's disease, there is a loss of these tonic signals as there is a loss of dopaminergic neurons of the nigrostriatal pathway. This reduced dopaminergic activity is compensated by the increased glutaminergic activity in the striatum.</p>\n<p>Levodopa that is administered in Parkinson's disease provides pulsatile (intermittent) signals to these dopamine receptors. Recent studies indicate that the <strong>overactivity</strong> of the <strong>glutaminergic neurons</strong> in the striatum and <strong>pulsatile dopaminergic therapy</strong> (instead of normal tonic stimulation)<strong> </strong>leads to altered signaling in the striatal neurons resulting in levodopa-induced dyskinesia.</p>\n<p>Amantadine <strong>inhibits</strong> the <strong>NMDA receptors</strong>(glutaminergic receptors) thereby mediating an anti-dyskinetic effect. It also has an anti-viral effect by interfering in the function of M2 protein and inhibiting viral replication. It is used in the treatment of influenza.</p>\n<p>Adverse effects:</p>\n<ul>\n<li><strong>Livedo reticularis </strong>is the appearance of non-blanching purplish dermal streaks</li>\n<li>Edema</li>\n<li>Contraindicated in renal, cardiovascular disease</li>\n</ul>\n<p>The image below shows <strong>livedo reticularis</strong>:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/72cf3ce8c782419a8b130cb0ccf0a764x600x448.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Apomorphine</strong> is a dopamine receptor agonist used in <strong>'off' episodes</strong> of levodopa therapy.</p>\n<p>Option B: <strong>Entacapone</strong> is a catechol-O-methyl transferase inhibitor and is used in <strong>'off' episodes</strong> and as adjunctive therapy in Parkinson's disease.</p>\n<p>Option D: <strong>Selegiline</strong> is an irreversible monoamine oxidase inhibitor-B and is used along with levodopa in mild or early Parkinson's disease.</p><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1961",
      "difficulty": "medium"
    },
    {
      "text": "An 8 month-old baby is brought to the pediatric clinic with symptoms of diarrhea, hair loss and failure to thrive. On clinical examination, there is inflammation of the skin around the mouth and the perianal region as shown in the image. What is the preferred drug to treat this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Oral iron therapy"
        },
        {
          "id": 2,
          "text": "Oral zinc therapy"
        },
        {
          "id": 3,
          "text": "Oral vitamin B12 therapy"
        },
        {
          "id": 4,
          "text": "Oral vitamin B6 therapy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A child with&nbsp;symptoms of diarrhea, hair loss, and eczematous rash typically in the perioral and perineal region is characteristic of <strong>acrodermatitis</strong> <strong>enteropathica</strong>. It is due to zinc deficiency.&nbsp;<strong>Oral zinc therapy</strong> is the preferred drug.</p>\n<p>Acrodermatitis enteropathica is an <strong>autosomal</strong> <strong>recessive</strong> disorder caused by a mutation in the <strong>intestinal</strong> <strong>zinc</strong> <strong>transporter</strong> <strong>gene</strong>,&nbsp;<strong>SLC39A4</strong>, found on <strong>chromosome 8q24.3</strong>,&nbsp;which leads to <strong>zinc deficiency.</strong></p>\n<p>Children commonly present with <strong>symmetrical, eczematous plaques</strong> that become <strong>vesicular, bullous, pustular, </strong>or<strong> erosive</strong> with characteristic crusting at the edges.&nbsp;The <strong>perioral eruption</strong> usually spares the upper lip.</p>\n<p>Diagnosis by clinical features and low plasma zinc levels. <strong>Oral zinc therapy</strong> is the treatment of choice (3 mg/kg/24 h).&nbsp;</p>\n<p><strong>Mnemonic-</strong>&nbsp;<strong>DEAL</strong> for Acrodermatitis enteropathica:</p>\n<p><strong>D &ndash; </strong><strong>D</strong>iarrhoea</p>\n<p><strong>E &ndash; E</strong>czematous dermatitis</p>\n<p><strong>A - A</strong>lopecia</p>\n<p><strong>L &ndash; L</strong>ethargy</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/643ab1da9fa94a059807e981eff59c64.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2861",
      "difficulty": "easy"
    },
    {
      "text": "An adolescent girl presents with the complaint of dropping objects from her hands during morning hours and during exams. There is no history of loss of consciousness. EEG shows 4-5 Hz polyspike-and-slow waves that are enhanced by photic stimulation. What is the drug of choice for seizures in this girl?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium valproate"
        },
        {
          "id": 2,
          "text": "Carbamazepine"
        },
        {
          "id": 3,
          "text": "Vigabatrin"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario points towards a diagnosis of <strong>j</strong><strong>uvenile myoclonic epilepsy (Janz syndrome).&nbsp;</strong>The drug of choice for the seizure in this girl is <strong>sodium valproate.&nbsp;</strong></p>\n<p>It is&nbsp;characterized by&nbsp;myoclonic jerks, which are most frequent in the <strong>morning</strong> with <strong>preserved consciousness</strong>. The jerks can manifest as<strong> dropping objects </strong>along with absence seizures.&nbsp;Sleep deprivation, alcohol, and <strong>photic stimulation</strong> act as triggers.&nbsp;The EEG shows <strong>4-5 polyspike</strong> and <strong>slow-wave discharges.&nbsp;</strong>Levetiracetam, lamotrigine, and topiramate are the other alternatives used.</p>\n<p>Other options:</p>\n<p>Option 3:&nbsp;<strong>Vigabatrin</strong>&nbsp;is the <strong>drug of choice</strong> for infantile spasm.</p>\n<p>EEG findings of JME are shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/333f4d0ddb1b43c4b8875d288b7d1641x800x389.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: First-line Agents in Different Types of Seizures</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2700",
      "difficulty": "easy"
    },
    {
      "text": "An HIV patient presents with fever, cough, chest discomfort, and shortness of breath for 1 week. On chest CT, a halo sign is seen.  On LPCB preparation, septate hyphae and conidiophores are seen. On the culture of bronchoalveolar lavage fluid, black colonies with galactomannan assay positive are obtained. Which of the following drugs is preferred in this condition?<div class='question-desc-html'><p>(LPCB- Lactophenol cotton blue)</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Itraconazole"
        },
        {
          "id": 2,
          "text": "Voriconazole"
        },
        {
          "id": 3,
          "text": "Amphotericin B"
        },
        {
          "id": 4,
          "text": "5-fluorocytosine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario is suggestive of <strong>acute</strong>&nbsp;<strong>invasive pulmonary aspergillosis.&nbsp;Voriconazole </strong>is the preferred drug in this condition.<strong>&nbsp;</strong></p>\n<p><strong>Invasive aspergillosis</strong>&nbsp;occurs due to infection with <em>Aspergillus</em> species. Most cases of invasive aspergillosis involve the lungs. The clinical features include fever, cough which may be productive, chest discomfort, hemoptysis, and shortness of breath.</p>\n<p>It is often seen in immunocompromised or debilitated due to prolonged treatment with antibiotics, steroids, and cytotoxics.</p>\n<p>Other manifestations of aspergillus species are allergic bronchopulmonary aspergillosis, aspergilloma, and superficial infections of the eye, external ear, and nasal sinuses.</p>\n<p>Diagnosis of invasive aspergillosis is made when the following findings are observed:</p>\n<ul>\n<li><strong>A positive culture</strong> from the affected organ</li>\n<li>Aspergillus antigen detection of <strong>galactomannan</strong></li>\n<li>Narrow, <strong>septate hyphae</strong> with branching at <strong>45<sup>o</sup></strong> and conidiophores</li>\n<li><strong>Halo sign</strong> on CT scan</li>\n</ul>\n<p>The image below shows <strong>septate hyphae</strong> with 45<sup>o</sup> branching and <strong>conidiophores</strong>:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/80af9a1ef8334da2a617f41d2fdfd658x512x191.PNG\" alt=\"Explanation Image\"><p>The image below shows the <strong>halo sign</strong> on the <strong>CT scan:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8ef240f3171b4a618f8d992495650e55x512x384.PNG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Itraconazole </strong>can be used for the treatment of <strong>chronic</strong> aspergillosis if there is <strong>resistance </strong>or<strong> failure of voriconazole</strong>.</p>\n<p>Option C: <strong>Amphotericin B</strong> is the drug of choice for <strong>mucormycosis</strong> and is the <strong>gold standard</strong> for <strong>induction treatment</strong> for <strong>cryptococcal meningitis</strong> when used in combination with 5-flucytosine. It can be used as a <strong>secondary treatment</strong> for invasive aspergillosis.</p>\n<p>Option D: <strong>5- fluorocytosine&nbsp;</strong>is useful in&nbsp;<strong>invasive candidiasis, </strong>and<strong>&nbsp;cryptococcal meningitis</strong>&nbsp;if combined with Amp B.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1899",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old man complained of low mood, decreased appetite, and loss of weight for the past 2 months. He mentions that he feels worthless and has decreased interest in activities. He also complains of great difficulty falling asleep. He has past history of atrial fibrillation. Which of the following drugs should be preferred for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Fluoxetine"
        },
        {
          "id": 2,
          "text": "Venlafaxine"
        },
        {
          "id": 3,
          "text": "Imipramine"
        },
        {
          "id": 4,
          "text": "Mirtazapine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient in the given clinical scenario has <strong>major depression</strong> with <strong>insomnia</strong>, <strong>decreased appetite</strong>, and <strong>weight loss</strong>. The preferred drug for this patient is <strong>mirtazapine</strong> as it is an antidepressant with <strong>sedative</strong> and <strong>appetite-stimulating</strong> properties.</p>\n<p><strong>Mirtazapine</strong> is an <strong>atypical antidepressant</strong> (a noradrenergic-specific serotonin antagonist). It blocks the presynaptic α<sub>2</sub> receptors and postsynaptic 5HT<sub>2</sub> and 5HT<sub>3</sub> receptors. The antagonism at serotonin receptors helps relieve anxiety<strong> </strong>and <strong>insomnia</strong> and <strong>stimulates</strong> <strong>appetite</strong>. It has a sedative property as it blocks the H<sub>1</sub> receptors. Mirtazapine is used in the treatment of <strong>major depression </strong>with long-standing <strong>insomnia</strong>.</p>\n<p>Adverse effects include sedation, increased appetite, weight gain, and rarely agranulocytosis. Sexual dysfunction is not a known side-effect of mirtazapine.</p>\n<p><strong>Atypical anti-depressants</strong> are those that act by <strong>unique mechanisms</strong> other than those of selective serotonin reuptake inhibitor (SSRI), serotonin-noradrenaline reuptake inhibitor (SNRI), MAO inhibitors, and tricyclic antidepressants. It includes drugs like <strong>trazodone</strong>, <strong>mianserin</strong>, <strong>bupropion</strong>, mirtazapine, and <strong>amoxapine</strong>.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Fluoxetine</strong> is an <strong>SSRI </strong>used in the treatment of <strong>major depression</strong>, obsessive-compulsive disorder, post-traumatic stress disorder, <strong>bulimia</strong> and <strong>anorexia nervosa</strong>, and generalized anxiety disorders. It may cause <strong>insomnia</strong>, and<strong> </strong>hence, it is avoided in this patient. Other adverse effects include anxiety, irritability, and decreased libido.</p>\n<p>Option B: <strong>Venlafaxine</strong> is an <strong>SNRI</strong> used in the treatment of <strong>major depression</strong>, generalized anxiety disorder, and panic disorder. It may cause <strong>insomnia</strong>, and hence, it is avoided in this patient. Other adverse effects are nausea,<strong> sexual dysfunction,</strong> and <strong>sustained elevation</strong> of <strong>blood pressure</strong>.</p>\n<p>Option C: <strong>Imipramine</strong> is a <strong>tricyclic antidepressant</strong> used in the treatment of <strong>major depression </strong>and<strong> nocturnal enuresis</strong>. Its use should be<strong> limited</strong> in <strong>heart diseases</strong> as it has quinidine-like effects on cardiac conduction, and hence, it is avoided in this patient.</p><hr><h3>Related Pearl: Adverse effects of specific antidepressants</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Drug</strong></p>\n</td>\n<td>\n<p><strong>Side effect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Amitriptyline</strong></p>\n</td>\n<td>\n<p>sedation, antimuscarinic, <strong>hypotension</strong>, <strong>arrhythmia,</strong> seizures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fluoxetine</strong></p>\n</td>\n<td>\n<p>Nausea, anorexia,<strong> loss of libido,</strong> insomnia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Trazodone</strong></p>\n</td>\n<td>\n<p>Sedative, <strong>priapism</strong>, hypotension</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bupropion</strong></p>\n</td>\n<td>\n<p>Seizures, mild tachycardia, hypertension</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mirtazapine</strong></p>\n</td>\n<td>\n<p>Sedative, increased appetite, weight gain</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1919",
      "difficulty": "hard"
    },
    {
      "text": "What is the chemotherapeutic agent of choice for the management of metastatic gastrointestinal stromal tumor?",
      "choices": [
        {
          "id": 1,
          "text": "Erlotinib"
        },
        {
          "id": 2,
          "text": "Imatinib"
        },
        {
          "id": 3,
          "text": "Sorafenib"
        },
        {
          "id": 4,
          "text": "Dasatinib"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Imatinib</strong> is the chemotherapeutic agent of choice for <strong>metastatic gastrointestinal stromal tumors </strong>(GIST).</p>\n<p><strong>Imatinib</strong> is a <strong>tyrosine kinase inhibitor</strong>. In GIST, it inhibits the mutant c-KIT gene. Its adverse effects include <strong>myelosuppression</strong>, diarrhea, nausea, vomiting, edema, and periorbital swelling.</p>\n<p><strong>Gastrointestinal stromal tumors (GIST) </strong>are <strong>mesenchymal</strong> <strong>tumors</strong> originating from the <strong>interstitial</strong> <strong>cells</strong> <strong>of</strong> <strong>Cajal</strong>, located in the gastrointestinal myenteric plexus. The most common mutation associated with GIST is the <strong>c-KIT </strong>gene mutation. They compromise 1-3% of all gastrointestinal tumors. The most common sites are the stomach, small bowel, and rectum. They are considered to have <strong>metastatic potential</strong> if <strong>larger than 5cm</strong>.</p>\n<p>Symptoms of GIST include pain abdomen, nausea, vomiting, hematemesis, and malena.</p>\n<p>They are diagnosed on <strong>endoscopy</strong> and can be confirmed by targeted biopsy by endoscopic ultrasound. The primary mode of treatment is <strong>surgical resection</strong> if they are easily resectable. Smaller tumors (&lt;5cm) are treated by wedge resection and larger tumors (&gt;5cm) may require gastrectomy or duodenectomy, with 3-6 months of <strong>imatinib therapy</strong> before operation. Imatinib therapy should be continued for large tumors with high malignant potential.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Erlotinib</strong> is an EGFR tyrosine kinase inhibitor. It is used in the management of <strong>non-small cell lung cancer</strong> and <strong>pancreatic cancer</strong>. </p>\n<p>Option C: <strong>Sorafenib</strong> is an intracellular kinase inhibitor. It is used in the management of <strong>hepatocellular carcinoma</strong>.</p>\n<p>Option D: <strong>Dasatinib</strong> is a BCR-ABL tyrosine kinase inhibitor. It is used in the management of<strong> imatinib-resistant CML</strong>.</p><hr><h3>Related Pearl: Indications for Imatinib</h3><p><strong>BCR-ABL kinase mutations</strong></p>\n<ul>\n<li>Chronic myelogenous leukaemia (CML)</li>\n<li>Acute lymphoblastic leukaemia (ALL)</li>\n</ul>\n<p><strong>C-KIT mutations</strong></p>\n<ul>\n<li>Gastrointestinal stromal tumors (GIST)</li>\n</ul>\n<p><strong>PDGFR mutations</strong></p>\n<ul>\n<li>Dermatofibrosarcoma protuberans</li>\n<li>Hypereosinophilia syndrome</li>\n<li>Chronic myelomonocytic leukaemia (CML)</li>\n</ul><hr><h3>Related Pearl: Gastrointestinal Stromal Tumor (GIST)</h3><p><strong>M/C mesenchymal tumor</strong> of GIT arising from <strong>interstitial cells of Cajal</strong> (pacemaker cells of GIT). <strong>Stomach is the m/c site.</strong></p>\n<p>GISTs express:</p>\n<ul>\n<li><strong>c-KIT (CD117)</strong></li>\n<li><strong>PDGF receptor A</strong></li>\n<li><strong>CD34</strong></li>\n<li><strong>SDH</strong></li>\n</ul>\n<p>Clinical Features:</p>\n<ul>\n<li>Peaks at 60 years of age.</li>\n<li>M/C symptom: Upper GI<strong> bleeding</strong></li>\n<li>Other symptoms: Pain, lump, perforation, incidental finding</li>\n<li><strong>Carney's Triad:</strong> Sporadic GIST, Paraganglioma, Pulmonary chondroma</li>\n</ul>\n<p>Management:</p>\n<ul>\n<li>IOC for <strong>primary </strong>GIST:<strong> CECT </strong>abdomen</li>\n<li>IOC for <strong>recurrent </strong>GIST:<strong> PET-CT</strong></li>\n<li><strong>IHC </strong>markers: <strong>CD117/C-KIT </strong>(M/C), <strong>DOG 1</strong> (most specific), CD 34</li>\n<li>Route of metastasis: Hematogenous</li>\n</ul>\n<p>The following image shows microscopy of GIST composed of spindle-shaped tumor cells:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/303296bfa2ad4afcbbed1a6e4a12a671x1280x1033.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Fletcher's</strong> classification (<strong>Tumor size</strong> &amp; <strong>No. of mitotic figures</strong>) is used to classify the tumors according to their malignancy risk.</li>\n<li><strong>Prognosis</strong> is determined by: Mitotic index, tumor size &amp; location of tumor (Stomach GISTs are less aggressive).</li>\n<li><strong>Complete surgical resection</strong> is the mainstay treatment. For <strong>unresectable</strong>, recurrent, or <strong>metastatic</strong> GISTs, <strong>imatinib</strong>, a tyrosine kinase inhibitor, can be used.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1960",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old female patient was posted for unilateral mastectomy for breast carcinoma. Halothane was used as the inhalational agent. Intraoperatively, she develops fever and tachycardia. On physical examination, rigidity was noted in the masseter muscle. What is the drug of choice for the management of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Succinylcholine"
        },
        {
          "id": 2,
          "text": "Dantrolene"
        },
        {
          "id": 3,
          "text": "Isoflurane"
        },
        {
          "id": 4,
          "text": "Vecuronium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario of a patient developing <strong>fever</strong>, <strong>tachycardia</strong>, and <strong>rigidity of the masseter muscle</strong> after being administered <strong>halothane</strong> is suggestive of <strong>malignant hyperthermia</strong>.<strong> </strong>The <strong>drug</strong> <strong>of</strong> <strong>choice</strong> for the condition is<strong> dantrolene</strong>.</p>\n<p>Dantrolene is a <strong>direct-acting</strong> skeletal muscle <strong>relaxant</strong> that acts on the <strong>RyR1</strong> (ryanodine receptor) <strong>calcium</strong> <strong>channels</strong> in the <strong>sarcoplasmic</strong> <strong>reticulum</strong> of skeletal muscles and <strong>inhibits calcium-induced calcium release</strong>. This results in the uncoupling of membrane depolarization and muscle contraction, thus inhibiting muscle contraction.</p>\n<p><strong>Malignant hyperthermia</strong> is a genetic condition in which <strong>mutated</strong> <strong>RyR1</strong><strong> receptors</strong> are present in the skeletal muscles. In the presence of certain triggers, this mutated RyR1 causes severe dysfunction in the RyR1 channels. This leads to the accumulation of calcium ions in the sarcoplasmic reticulum resulting in sustained muscle contraction, rigidity, increased heat production, acidosis, hyperkalemia, and increased end-tidal CO<sub>2</sub>. Patients with <strong>positive family history</strong> and patients with <strong>congenital myopathies</strong> are at <strong>increased risk</strong> for the development of this condition.</p>\n<p>Drugs triggering malignant hyperthermia:</p>\n<ul>\n<li>Succinylcholine</li>\n<li>Halothane</li>\n<li>Isoflurane</li>\n<li>Sevoflurane</li>\n</ul>\n<p>Dantrolene<strong> </strong>sodium is the drug<strong> </strong>of<strong> </strong>choice for malignant hyperthermia. Once the diagnosis is made, the causative inhalational agent should be stopped immediately. Supportive management includes rapid cooling, inhalation of 100% oxygen, control of acidosis, and treatment of hyperkalemia.</p>\n<p>Other options:</p>\n<p>Options A and C: <strong>Succinylcholine</strong> and <strong>isoflurane</strong> are known to cause malignant hyperthermia, and hence cannot be used for the management.</p>\n<p>Option D: <strong>Vecuronium</strong> is a non-depolarizing skeletal muscle relaxant. It is not indicated for the management of malignant hyperthermia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1946",
      "difficulty": "easy"
    },
    {
      "text": "What is the treatment of choice to ameliorate the non-neural manifestations of mucopolysaccharidosis II?",
      "choices": [
        {
          "id": 1,
          "text": "Aldurazyme"
        },
        {
          "id": 2,
          "text": "Alglucosidase alfa"
        },
        {
          "id": 3,
          "text": "Elaprase"
        },
        {
          "id": 4,
          "text": "Nagalzyme"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Elaprase </strong>(recombinant iduronate-2-sulfatase) is the treatment of choice to ameliorate the non-neural manifestations of mucopolysaccharidosis II/<strong>Hunter syndrome</strong>.</p>\n<p><strong>Mucopolysaccharidoses</strong> are a group of <strong>lysosomal storage</strong> metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. There are 7 distinct classes of mucopolysaccharidosis which are further subcategorized.</p>\n<p><strong>Hunter syndrome</strong> is an <strong>X-linked recessive</strong> disorder caused due to deficiency of <strong>iduronate-2-sulfatase</strong>. This enzyme deficiency leads to the accumulation of <strong>heparan sulfate</strong> and <strong>dermatan sulfate.</strong> It almost exclusively manifests in males.</p>\n<p><strong>Clinical features</strong> of Hunter syndrome are similar to Hurler syndrome (mucopolysaccharidosis I) <strong>except</strong> for the <strong>corneal clouding</strong> and slow progression of central nervous system deterioration. Other features are:</p>\n<ul>\n<li>Short stature</li>\n<li>Hearing impairment</li>\n<li>Coarse facial features</li>\n<li>Mongolian spots</li>\n<li>Joint stiffness, carpal tunnel syndrome</li>\n<li>Chronic diarrhea</li>\n<li>Valvular cardiac disease</li>\n<li>Intellectual disability</li>\n<li>Spastic paraplegia</li>\n<li>Communicating hydrocephalus</li>\n</ul>\n<p>Diagnosis:</p>\n<ul>\n<li>Newborn screening using dried blood spots</li>\n<li>Semiquantitative analysis of increased urinary glycosaminoglycans(GAG)</li>\n<li>Quantitative analysis of single GAG</li>\n<li>Definitive diagnosis by <strong>enzyme assay</strong></li>\n</ul>\n<p><strong>Elaprase </strong>(recombinant iduronate-2-sulfatase)<strong> </strong>is the treatment of choice to ameliorate the <strong>non-neural manifestations</strong>. Early hematopoietic stem cell transplantation may have some effects. Hematopoietic stem cell transplantation when done before 9 months of age results in normal cognitive development. Transplantation does not have any effect on neuropsychological manifestation when impaired cognition is already present at the time of transplantation. Symptomatic therapy is given for most neurological manifestations.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Aldurazyme </strong>(recombinant L-iduronidase) is approved as enzyme replacement therapy for <strong>Hurler syndrome </strong>(mucopolysaccharidosis I).</p>\n<p>Option B: <strong>Alglucosidase alfa </strong>(recombinant α-glucosidase) is the enzyme replacement therapy for <strong>Pompe disease.</strong></p>\n<p>Option D: <strong>Nagalzyme </strong>(recombinant N-acetylgalactosamine-4-sulfatase) is the enzyme replacement therapy for <strong>Maroteux-Lamy syndrome </strong>(mucopolysaccharidosis VI).</p><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Enzyme Replacement Therapy for Lysosomal Storage Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Lysosomal Storage Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficient</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Replacement Therapy</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hurler Syndrome (MPS I)</p>\n</td>\n<td>\n<p>&alpha;-L -iduronidase</p>\n</td>\n<td>\n<p>Laronidase (Aldurazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hunter Syndrome (MPS II)</p>\n</td>\n<td>\n<p>Iduronate sulfate sulfatase</p>\n</td>\n<td>\n<p>Idursulfase (Elaprase)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Morquio A Syndrome (MPS IVA)</p>\n</td>\n<td>\n<p>N-Acetylgalactosamine-6-sulfate sulfatase</p>\n</td>\n<td>\n<p>Elosulfase (Vimizim)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maroteaux&ndash;Lamy Syndrome (MPS VI)</p>\n</td>\n<td>\n<p>N -Acetylgalactosamine-&alpha;-4-sulfate sulfatase (arylsulfatase B)</p>\n</td>\n<td>\n<p>Galsulfase (Naglazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sly syndrome (MPS VII)</p>\n</td>\n<td>&beta;-Glucuronidase</td>\n<td>\n<p>rhGUS (recombinant human&nbsp;&beta;-Glucuronidase is under Phase III trial)</p>\n</td>\n</tr>\n<tr>\n<td>Wolman disease</td>\n<td>Lysosomal acid lipase</td>\n<td>\n<p><em> Sebelipase alfa</em>(Kanuma, Alexion)</p>\n</td>\n</tr>\n<tr>\n<td>Metachromatic leukodystrophy</td>\n<td>Arylsulfatase A</td>\n<td>\n<p>rhARSA (recombinant human arylsulfatase A is under Phase I/II trial)</p>\n</td>\n</tr>\n<tr>\n<td>Fabry disease&nbsp;</td>\n<td>&alpha;-galactosidase A</td>\n<td>\n<p><em>agalsidase beta</em> (Fabrazyme, Genzyme)</p>\n<p><em>agalsidase alfa</em> (Replagal, Shire HGT)</p>\n</td>\n</tr>\n<tr>\n<td>Gaucher disease</td>\n<td>&beta;-glucosidase</td>\n<td>\n<p><em>imiglucerase </em>[Cerezyme, Genzyme]</p>\n<p><em>velaglucerase alfa </em>[VPRIV, Shire HGT]</p>\n<p><em>taliglucerase alfa </em>(Uplyso, Protalix<br />Biotherapeutics)</p>\n<p><em>eliglusta</em>t (Cerdelga, Sanofi-Genzyme)</p>\n</td>\n</tr>\n<tr>\n<td>Pompe disease</td>\n<td>acid &alpha;-1,4-glucosidase (acid maltase)&nbsp;</td>\n<td>\n<p><em>alglucosidase alfa </em>(Myozyme)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1913",
      "difficulty": "hard"
    },
    {
      "text": "A 30-year-old woman presented with itching and malodorous discharge in the vagina. Whiff's test was positive and microscopy of the discharge is shown below.  What is the drug of choice for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Ampicillin"
        },
        {
          "id": 2,
          "text": "Ciprofloxacin"
        },
        {
          "id": 3,
          "text": "Metronidazole"
        },
        {
          "id": 4,
          "text": "Clotrimazole"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario, a positive Whiff test and clue cells on microscopy point towards a diagnosis of <strong>bacterial vaginosis.&nbsp;Metronidazole&nbsp;</strong>(oral or intravaginal) or intravaginal <strong>clindamycin </strong>are considered the drugs of choice.&nbsp;</p>\n<p>The male partner should be treated in case of recurrent infections of bacterial vaginosis.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e4449bab169741b798f3407876a157bf.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7782",
      "difficulty": "easy"
    },
    {
      "text": "A 55-year-old female patient presents with diminished vision, headache, and eye pain. She had a history of herpes infection. On examination, there is an increase in IOP. The ophthalmologist prescribes an eye drop for increased  IOP. After a week, the patient presents with herpetic keratitis. Which of the following is the most likely drug to have favored the development of herpetic keratitis?<div class='question-desc-html'><p>(IOP- Intraocular pressure)</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Timolol"
        },
        {
          "id": 2,
          "text": "Latanoprost"
        },
        {
          "id": 3,
          "text": "Brimonidine"
        },
        {
          "id": 4,
          "text": "Dorzolamide"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Latanoprost</strong> is the most likely drug to have favored the development of herpetic keratitis in this patient.</p>\n<p><strong>Latanoprost</strong> is a <strong>prostaglandin analogue</strong> and acts by increasing the uveoscleral outflow thus reducing the IOP. Latanoprost is <strong>preferred</strong> over β-blockers due to its decreased systemic side effects. </p>\n<p>Prostaglandin analogues induce the release of endogenous prostaglandins in the iris and ciliary which enhances the cell-to-cell spread of HSV resulting in reactivation of the herpes infection. </p>\n<p>Adverse effects:</p>\n<ul>\n<li><strong>conjunctival hyperaemia</strong></li>\n<li><strong>eyelash thickening</strong> </li>\n<li><strong>iris pigmentation</strong> </li>\n<li>promotion of <strong>herpetic keratitis </strong>in a patient with a <strong>history of herpes infection</strong></li>\n<li>if used preoperatively, cystoid macular edema following cataract surgery</li>\n</ul>\n<p><strong>Primary open-angle glaucoma </strong><span>(POAG)</span><strong> </strong><span>is a bilateral, symmetrical disease with an adult-onset type. In this condition, there is an increase in the IOP due to trabecular sclerosis leading to decreased aqueous outflow. The clinical features include headache, difficulty in dark adaptation, frequent change of glasses, and blurring of vision. </span></p>\n<p>On ocular examination, an <strong>open anterior chamber angle</strong>, <strong>glaucomatous optic nerve head changes</strong>, <strong>visual field defect</strong>s, and an <strong>increased IOP</strong> of more than <strong>21mmHg </strong>are noted.</p>\n<p>Other options:</p>\n<p>Option A- Timolol is a <strong>non-selective β-blocker</strong> that decreases the IOP by <strong>reducing</strong> the <strong>aqueous humor production</strong> through blockade of the <strong>β-receptors</strong> on the <strong>ciliary epithelium. </strong>The adverse effects include:</p>\n<ul>\n<li>Ocular effects are allergy, decreased corneal sensation, and <strong>punctate keratitis</strong></li>\n<li>Systemic effects-\n<ul>\n<li>Potentially fatal <strong>bronchospasm</strong> in <strong>asthmatic patients</strong> and reversible airway diseases due to blockade of β<sub>2</sub> receptors in bronchial smooth muscle</li>\n<li>Heart blocks, bradycardia, worsening of heart failure, and hypotension are some of the cardiovascular adverse effects</li>\n</ul>\n</li>\n</ul>\n<p>Option C- <strong>Brimonidine</strong> is a <strong>selective alpha-2</strong> <strong>agonist </strong>which decreases aqueous synthesis and increases uveoscleral outflow. It can cross the blood-brain barrier and, hence, causes <strong>drowsiness and CNS depression</strong>. It is <strong>contraindicated</strong> in <strong>infants</strong> and <strong>children</strong>.</p>\n<p>Option D- <strong>Dorzolamide</strong> is a topical <strong>carbonic anhydrase inhibitor</strong> that decreases IOP by reducing aqueous formation. The main adverse effect is the <strong>bitter taste</strong> following administration. It is <strong>contraindicated</strong> in people with allergies to sulfonamide antibiotics. </p><hr><h3>Related Pearl: Antiglaucoma drugs: Mechanism of lowering intraocular pressure (IOP) at a glance</h3><p><strong>Drugs that increase trabecular outflow</strong></p>\n<ul>\n<li>Miotics (e.g., pilocarpine)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Bimatoprost</li>\n<li>Rho-kinase inhibitor (Netarsudil)</li>\n</ul>\n<p><strong>Drugs that increase uveoscleral outflow</strong></p>\n<ul>\n<li>Prostaglandins (latanoprost)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Brimonidine</li>\n<li>Apraclonidine</li>\n</ul>\n<p><strong>Drugs that decrease aqueous production</strong></p>\n<ul>\n<li>Carbonic anhydrase inhibitors (e.g., acetazolamide, dorzolamide)</li>\n<li>Alpha receptor stimulators in ciliary process (e.g., epinephrine, dipivefrine, clonidine, brimonidine, apraclonidine)</li>\n<li>Beta-blockers</li>\n</ul>\n<p><strong>Hyperosmotic agents</strong> - (e.g., glycerol, mannitol, urea)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/52d74961d2524b3bb5c22c2677259778x1280x1532.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1909",
      "difficulty": "medium"
    },
    {
      "text": "What is the drug of choice for lithium-induced nephrogenic diabetes insipidus?",
      "choices": [
        {
          "id": 1,
          "text": "Demeclocycline"
        },
        {
          "id": 2,
          "text": "Thiazide diuretics"
        },
        {
          "id": 3,
          "text": "Tolvaptan"
        },
        {
          "id": 4,
          "text": "Amiloride"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The<strong> drug of choice</strong> for <strong>lithium-induced nephrogenic diabetes</strong> <strong>insipidus</strong> is <strong>amiloride</strong>.</p>\n<p>Amiloride belongs to the <strong>K<sup>+</sup>-sparing diuretic group</strong>. It is a renal epithelial Na<sup>+</sup> channel(ENac) inhibitor in collecting duct cells. Lithium enters through the ENac and inhibits the action of the anti-diuretic hormone. Amiloride <strong>blocks</strong> the<strong> entry </strong>of<strong> Li<sup>+</sup> </strong>ion through the<strong> ENac</strong> and thus mitigates diabetes insipidus induced by lithium.</p>\n<p>The most important adverse effect of amiloride is <strong>hyperkalemia</strong>. Other adverse effects include nausea, vomiting, diarrhoea, and headache.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Demeclocycline</strong> belongs to the tetracycline group of antibiotics. It interferes with the anti-diuretic hormone action but is used in the <strong>treatment</strong> of the syndrome of inappropriate antidiuretic hormone(<strong>SIADH</strong>). </p>\n<p>Option B: <strong>Thiazide diuretics</strong> inhibit the <strong>Na<sup>+</sup>-Cl<sup>-</sup> symport</strong> present in the distal convoluted tubule of the nephron. It is used in the <strong>treatment</strong> of <strong>nephrogenic diabetes insipidus</strong> by decreasing the ability of the kidney to excrete free water. It increases the reabsorption of water in the proximal tubule and reduces the ability of the distal tubule to dilute the urine. </p>\n<p>Option C: <strong>Tolvaptan</strong> is a vasopressin antagonist used in the treatment of SIADH, hypervolemic and euvolemic hyponatremia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9490",
      "difficulty": "medium"
    },
    {
      "text": "A 22-year-old male patient complains of pruritis. He feels intense pruritus and has painful, red streaks between his fingers and in the groin area. He states that the itchiness is worse at night. Other students from his college dormitory also present with similar complaints. An image of his skin on physical examination is shown below. Which of the following can be used for the treatment of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "5 % permethrin cream"
        },
        {
          "id": 2,
          "text": "Oral albendazole"
        },
        {
          "id": 3,
          "text": "5% lindane lotion"
        },
        {
          "id": 4,
          "text": "Topical corticosteroids"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette describes a case of <strong>scabies</strong>. Management of scabies involves&nbsp;topical application <strong>of 5%</strong> <strong>permethrin cream.</strong></p>\n<p>The image shows a magnified view of a <strong>burrowing trail of the scabies mite</strong>. The scaly patch on the left was caused by the scratching and marks the mite's entry point into the skin. The mite has burrowed to the top-right, where it can be seen as a dark spot at the end. <strong>Burrow</strong> is the characteristic lesion of scabies.</p>\n<p><strong>Scabies</strong> is an <strong>ectoparasitic</strong> <strong>infestation</strong> caused in humans by the <strong>Sarcoptes scabiei var. hominis.</strong></p>\n<p>The characteristic symptoms of a scabies infection include <strong>intense itching</strong> and <strong>superficial</strong> <strong>burrows</strong>.&nbsp;Burrows present as slightly raised <strong>brownish tortuous</strong> lesions. It is&nbsp;created by the excavation of the <strong>adult</strong> <strong>mite</strong> in the <strong>epidermis</strong>.&nbsp;In most people, the trails of the burrowing mites are <strong>linear</strong>&nbsp;in the skin.</p>\n<p>Typical locations of lesions are the <strong>finger webs, the flexor surfaces of the wrists</strong>, the elbows, the axillae, the buttocks and genitalia, and the breasts of women.</p>\n<p>Other treatment options - topical application of <strong>1% lindane lotion</strong>, benzyl benzoate, esdepalletrin (bioallethrin), crotamiton, and precipitated sulfur.</p>\n<p>Other options:</p>\n<p>Option B- <strong>Oral albendazole</strong> is used in the treatment of <strong>larva currens</strong> and <strong>c</strong><strong>utaneous larva migrans. </strong>They&nbsp;present as&nbsp;pruritic erythematous papules at the site of penetration of the hookworms with an erythematous serpiginous larva track.</p>\n<p>The image below shows <strong>cutaneous larva migrans</strong>:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c80ed4ef43b14c0ca07ac4283d6bf16cx720x633.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image below shows <strong>larva currens:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2de7648a4da64427b815b68715998fd9x720x473.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option D<strong>- Topical corticosteroids</strong>&nbsp;are used in certain cases of<strong> bed bugs</strong>. They present as pruritic maculopapular lesions with a visible hemorrhagic punctum in the center. Three or four lesions may be arranged in a line or a curve pattern which is called <strong>breakfast‐lunch‐dinner alignment.&nbsp;</strong></p>\n<p>The image below shows<strong> bed bug bites:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e9ec1c51295749369a99ad75f9ae745dx720x749.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Difference between classic and neonatal scabies</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Classic scabies</strong></td>\n<td><strong>Neonatal scabies</strong></td>\n</tr>\n<tr>\n<td>Site of involvement</td>\n<td>Interdigital webs, trunk, genitals, flexors, sparing of palms and soles, and skin above neck</td>\n<td>Face, scalp, palm, and soles</td>\n</tr>\n<tr>\n<td>Morphology of Lesion</td>\n<td>Papules, pustules, excoriation, eczematization, burrow</td>\n<td>Vesicles, pustules, bullae, erosions, and ulcerations</td>\n</tr>\n<tr>\n<td>Burrows</td>\n<td>Present</td>\n<td>Usually absent</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/42fad614b73f47d4b8413d567cf3dd8b.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8386",
      "difficulty": "easy"
    },
    {
      "text": "An elderly male patient with a history of  Mycobacterium avium complex infection presented with fatigue and a dragging sensation in the left upper abdomen. On examination, massive splenomegaly with no lymphadenopathy was found. His peripheral smear is as shown below. What is the drug of choice for this malignancy?<div class='question-desc-html'><p>Blood routine report- Pancytopenia</p>\n<p>Bone marrow aspirate- dry tap</p>\n<p>Immunohistochemistry</p>\n<table>\n<tbody>\n<tr>\n<td>CD19&nbsp; &nbsp; &nbsp; -</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>CD22&nbsp; &nbsp; &nbsp; -</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>CD11c&nbsp; &nbsp; &nbsp;-</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>CD25&nbsp; &nbsp; &nbsp; -</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>CD103&nbsp; &nbsp; -</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>CD123&nbsp; &nbsp; -</td>\n<td>Positive</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Vemurafenib"
        },
        {
          "id": 2,
          "text": "Pentostatin"
        },
        {
          "id": 3,
          "text": "Interferon α"
        },
        {
          "id": 4,
          "text": "Cladribine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario and the findings of leukemic cells&nbsp;with<strong> fine hair-like projections</strong> in the peripheral smear are suggestive of<strong>&nbsp;</strong>hairy cell leukemia. <strong>Cladribine</strong> is the <strong>drug of choice</strong> for the treatment of <strong>hairy cell leukemia.</strong></p>\n<p>Hairy cell leukemia is responsive to chemotherapy with interferon &alpha;, pentostatin, and cladribine. However, cladribine, <strong>a purine analogue</strong> is the preferred drug of choice as complete remission with cladribine occurs clinically in the majority of patients and long-term disease-free survival is frequent.&nbsp;Cladribine is administered daily for 7 days by continuous intravenous infusion.</p>\n<p>Chemotherapy-refractory patients have&nbsp;responded to <strong>vemurafenib, a BRAF inhibitor.</strong></p>\n<p>Splenectomy is often&nbsp;associated with prolonged remission.</p><p><strong>Hairy cell Leukemia:</strong></p>\n<p>Most patients present with symptoms of&nbsp;<strong>cytopenias</strong>&nbsp;or&nbsp;<strong>splenomegaly</strong>.&nbsp;<strong>Dry tap</strong>&nbsp;is obtained upon performing bone marrow aspiration due to HCL-induced marrow fibrosis and the interlocking cell borders of hairy cells (do not confuse with myelofibrosis).</p>\n<p><strong>CD11c, CD25, CD103, CD123</strong>&nbsp;are the characteristic immunophenotypes diagnostic of Hairy cell leukemia. Pan-B markers such as&nbsp;<strong>CD19, CD20, and CD22</strong>&nbsp;can also test positive for Hairy cell leukemia.</p>\n<p>There is an increased incidence of&nbsp;<strong>atypical mycobacterial infections (<em>Mycobacterium avium-intracellulare</em>)</strong>&nbsp;in hairy cell leukemia. This is possibly related to frequent unexplained&nbsp;<strong>monocytopenia</strong>. Out of the atypical mycobacteria,&nbsp;<em><strong>Mycobacterium kansasii</strong>&nbsp;</em>infection is a unique feature of hairy-cell leukemia.</p>\n<p><strong>Staining:</strong></p>\n<p>Annexin A1 on bone marrow specimens has been shown to have 100% sensitivity and specificity in differentiating hairy cell leukemia from other B cell malignancies.&nbsp;</p>\n<p>Tartrate-resistant acid phosphatase&nbsp;<strong>(TRAP) stain</strong>&nbsp;is an important tool in the clinical diagnosis of hairy cell leukemia and yields positive results in&nbsp;&asymp;95% of the cases.</p>\n<p><strong>Hairy cells</strong>&nbsp;on&nbsp;Wright-stained peripheral blood smear is an important diagnostic finding. However, these can be seen in other B-cell disorders also.</p>\n<p>Typical hairy cells are&nbsp;<strong>mononuclear cells</strong>&nbsp;with abundant&nbsp;<strong>pale blue-grey agranular cytoplasm</strong>&nbsp;with elongated (<strong>hairy</strong>) projections.</p>\n<p>Fried eggs in pathology:</p>\n<ul>\n<li><strong>Oligodendroglioma</strong>&nbsp;on histopathology</li>\n<li><strong>Hairy cell leukemia</strong>&nbsp;on bone marrow biopsy</li>\n<li><strong>Seminoma/Dysgerminoma</strong>&nbsp;on light microscopy</li>\n<li><strong>Mycoplasma pneumonia</strong>&nbsp;fried egg colonies on&nbsp;<strong>Eaton agar</strong></li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ff324cc45a924a0d885c240d2b8ff5a1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME1160",
      "difficulty": "medium"
    }
  ]
}